Matches in Nanopublications for { ?s ?p "[This study suggests that the CYP2C9 polymorphism may be involved in the lipid-lowering efficacy of rosuvastatin in patients with hyperlipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion description "[This study suggests that the CYP2C9 polymorphism may be involved in the lipid-lowering efficacy of rosuvastatin in patients with hyperlipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_provenance.